Cite

HARVARD Citation

    Tsuchiya, K. et al. (2021). YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer. Oncoimmunology. p. . [Online]. 
  
Back to record